Presence of high-endothelial venules correlates with a favorable immune microenvironment in oral squamous cell carcinoma

Enrichment of Human CCR6+Regulatory T Cells with Superior Suppressive Activity in Oral Cancer

(2017) Jang-Jaer Lee et al.   JOURNAL OF IMMUNOLOGY

Biomarkers along the continuum of care in lung cancer

(2016) Stefan Holdenrieder   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview

(2016) Vilma Oliveira Frick   WORLD JOURNAL OF GASTROENTEROLOGY

CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma

(2015) J Y Liu et al.   BRITISH JOURNAL OF CANCER

PD-L1 Blockade for Cancer Treatment: MEDI4736

(2015) Ramy Ibrahim et al.   SEMINARS IN ONCOLOGY

The Next Hurdle in Cancer Immunotherapy: Overcoming the Non–T-Cell–Inflamed Tumor Microenvironment

(2015) Thomas F. Gajewski   SEMINARS IN ONCOLOGY

The STING pathway and the T cell-inflamed tumor microenvironment

(2015) Seng-Ryong Woo et al.   TRENDS IN IMMUNOLOGY

Presence of tumour high-endothelial venules is an independent positive prognostic factor and stratifies patients with advanced-stage oral squamous cell carcinoma

(2015) Anna M. Wirsing et al.   TUMOR BIOLOGY

Microlocalization of CD68+ tumor-associated macrophages in tumor stroma correlated with poor clinical outcomes in oral squamous cell carcinoma patients

(2015) Yan-Hong Ni et al.   TUMOR BIOLOGY

The role of the PD-L1:PD-1 pathway in squamous cell carcinoma of the head and neck

(2014) Dan P. Zandberg et al.   ORAL ONCOLOGY

Clinicopathological characteristics of oral squamous cell carcinoma in Northern Norway: a retrospective study

(2014) Oddveig G Rikardsen et al.   BMC Oral Health

Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma

(2013) S. Lyford-Pike et al.   CANCER RESEARCH

Prognostic molecular markers in cancer - quo vadis?

(2013) Tine M Søland et al.   HISTOPATHOLOGY

Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells

(2013) S. Spranger et al.   Science Translational Medicine

The increase in incidence of cancer of the tongue in the Nordic countries continues into the twenty-first century

(2012) Karin Annertz et al.   ACTA OTO-LARYNGOLOGICA

Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration

(2012) Douglas G Altman et al.   BMC Medicine

PD-1-Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer

(2012) C. Badoual et al.   CANCER RESEARCH

Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer

(2012) Charles C. L. Tong et al.   IMMUNOLOGIC RESEARCH

Cancer-associated fibroblasts and CD163-positive macrophages in oral squamous cell carcinoma: their clinicopathological and prognostic significance

(2012) Nobuyuki Fujii et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

(2012) Julie R. Brahmer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

(2012) Suzanne L. Topalian et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tumor high endothelial venules (HEVs) predict lymphocyte infiltration and favorable prognosis in breast cancer

(2012) Ludovic Martinet et al.   OncoImmunology

High endothelial venules (HEVs) in human melanoma lesions

(2012) Ludovic Martinet et al.   OncoImmunology

Human Solid Tumors Contain High Endothelial Venules: Association with T- and B-Lymphocyte Infiltration and Favorable Prognosis in Breast Cancer

(2011) L. Martinet et al.   CANCER RESEARCH

Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules

(2011) Christine Moussion et al.   NATURE

Selective Recruitment of Regulatory T Cell through CCR6-CCL20 in Hepatocellular Carcinoma Fosters Tumor Progression and Predicts Poor Prognosis

(2011) Kang-Jie Chen et al.   PLoS One

Neogenesis and development of the high endothelial venules that mediate lymphocyte trafficking

(2010) Haruko Hayasaka et al.   CANCER SCIENCE

PD-1 and PD-L1 upregulation promotes CD8+ T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients

(2010) Feng Shi et al.   INTERNATIONAL JOURNAL OF CANCER

CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes

(2010) B. H. Nelson   JOURNAL OF IMMUNOLOGY

Increase of programmed death-1-expressing intratumoral CD8 T cells predicts a poor prognosis for nasopharyngeal carcinoma

(2010) Mei-Chi Hsu et al.   MODERN PATHOLOGY

Tumor-infiltrating lymphocytes, particularly the balance between CD8+ T cells and CCR4+ regulatory T cells, affect the survival of patients with oral squamous cell carcinoma

(2010) Yoshiko Watanabe et al.   ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS

Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma

(2009) Dominik Pretscher et al.   BMC CANCER

Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment

(2009) Thaís Helena Gasparoto et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

PD-1 and Its Ligands in Tolerance and Immunity

(2008) Mary E. Keir et al.   Annual Review of Immunology

Human Leukocyte Antigen Class I, MHC Class I Chain-Related Molecule A, and CD8+/Regulatory T-Cell Ratio: Which Variable Determines Survival of Cervical Cancer Patients?

(2008) E. S. Jordanova et al.   CLINICAL CANCER RESEARCH

Intratumoral rhIL-12 administration in head and neck squamous cell carcinoma patients induces B cell activation

(2008) Carla M.L. van Herpen et al.   INTERNATIONAL JOURNAL OF CANCER